Educational protocol hub
Cartalax: protocol variants and reconstitution resources
Educational hub for Cartalax, grouping 1 available protocol variant with links to the exact dosage and reconstitution pages.
What this hub covers
This page groups the available Cartalax protocol variants so readers can choose the exact vial-size guide without mixing formats.
Reconstitution workflow
Use the linked protocol pages and calculator resources to review concentration, diluent logic and unit conversions for the selected variant.
Research-only context
All information is educational and literature-focused. AllPeptides.eu does not sell peptides and does not provide medical advice.
Available protocol variants
Choose the exact guide you want to view.
Cartalax
Cartalax is a synthetic tripeptide bioregulator (Ala-Glu-Asp; 'AED' sequence) developed by Prof. Vladimir Khavinson. Preclinical studies indicate it may regulate fibroblast proliferation markers (Ki-67), reduce pro-apoptotic signaling (p53, caspase-3), and support extracellular matrix homeostasis. This protocol outlines a once-daily subcutaneous approach.
View protocolRelated research resources
Internal links that help readers and search engines understand this peptide topic cluster.
References
- Neuroendocrinology Letters (2002) — Khavinson: bioregulatory peptides and geroprotection
View Source - Bull Exp Biol Med (2016) — Peptide regulation of skin fibroblasts during in vitro aging
View Source - Bull Exp Biol Med (2014) — Peptides regulate signaling molecules in aging renal cells
View Source - Linkova N et al. Int J Mol Sci 2023 — Peptide Regulation of Chondrogenic Stem Cell Differentiation.
View Source - Advances in Gerontology (2020) — Short peptides: regulation of skin function during aging
View Source
Educational and laboratory research information only. AllPeptides.eu does not sell peptides and does not provide medical advice or human-use instructions.